Regeneron Pharmaceuticals Property, plant and equipment, net increased by 2.8% to $5.27B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.2%, from $4.69B to $5.27B. Over 5 years (FY 2020 to FY 2025), Property, plant and equipment, net shows an upward trend with a 9.7% CAGR.
An increase indicates capital expansion and infrastructure investment, while a decrease suggests asset depreciation or divestment.
This represents the net book value of long-term physical assets such as office buildings, data center infrastructure, an...
Standard line item across all capital-intensive industries, often referred to as 'Net PP&E'.
non_current_assets_property_plant_and_equipment_and_fina_e3effd| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.48B | $3.76B | $3.88B | $3.92B | $4.01B | $4.15B | $4.23B | $4.31B | $4.44B | $4.60B | $4.69B | $4.84B | $5.00B | $5.12B | $5.27B |
| QoQ Change | — | +8.1% | +3.1% | +1.1% | +2.1% | +3.5% | +1.9% | +1.9% | +3.1% | +3.6% | +2.1% | +3.1% | +3.3% | +2.4% | +2.8% |
| YoY Change | — | +8.1% | — | — | — | +10.2% | +8.9% | +9.8% | +10.8% | +10.9% | +11.1% | +12.4% | +12.7% | +11.3% | +12.2% |
| Segment | Q4 '21 |
|---|---|
| Rest Of World | $797.80M |
| Total | $3.48B |
Rest Of World was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
| Segment | Q4 '24 | Q4 '25 |
|---|---|---|
| Outside United States | $715.90M | $788.00M |
| Total | $4.60B | $5.12B |